MENU
BMRN
AS OF
Dec 24 closing price
Price
$60.16
Change
-$0.98 (-1.60%)
Capitalization
11.56B
62 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
BMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioMarin Pharmaceutical (BMRN) Earnings Date & Reports

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

BMRN is expected to report earnings to rise 577.92% to 81 cents per share on February 25

BioMarin Pharmaceutical BMRN Stock Earnings Reports
Q4'25
Est.
$0.81
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.61
Q1'25
Beat
by $0.43
Q4'24
Beat
by $0.37
The last earnings report on October 27 showed earnings per share of 11 cents, beating the estimate of -7 cents. With 1.21M shares outstanding, the current market capitalization sits at 11.56B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BMRN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMRN showed earnings on October 27, 2025. You can read more about the earnings report here.
View AI-Driven Trading for BMRN
A.I. Advisor
published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com